Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.
about
Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with NumbAmyloid precursor protein and amyloid precursor-like protein 2 in cancerSplicing Regulation: A Molecular Device to Enhance Cancer Cell AdaptationNrf2 and Notch Signaling in Lung Cancer: Near the CrossroadLarge-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networksAnalysis of the transcriptome in molecular epidemiology studiesNotch is a critical regulator in cervical cancer by regulating Numb splicing.Aberrant regulation of FBW7 in cancer.RNA-Seq quantification of the human small airway epithelium transcriptomeIdentification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.Identification and characterization of alternative exon usage linked glioblastoma multiforme survivalDistinct types of disorder in the human proteome: functional implications for alternative splicing.Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.Transcriptome profiling of a multiple recurrent muscle-invasive urothelial carcinoma of the bladder by deep sequencing.TBX3 regulates splicing in vivo: a novel molecular mechanism for Ulnar-mammary syndrome.The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.Splicing programs and cancerMiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.A semi-supervised approach uncovers thousands of intragenic enhancers differentially activated in human cells.Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancerLeveraging transcript quantification for fast computation of alternative splicing profiles.Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates.Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteinsSpectraplakins: master orchestrators of cytoskeletal dynamics.Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma.hnRNP I regulates neonatal immune adaptation and prevents colitis and colorectal cancer.Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levelsEmerging roles for Sam68 in adipogenesis and neuronal development.Identification of Alternative Splicing and Fusion Transcripts in Non-Small Cell Lung Cancer by RNA SequencingEpstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.Functional understanding of the diverse exon-intron structures of human GPCR genes.NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.Expression of Notch1 and Numb in small cell lung cancer.Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.Identification of miRNA biomarkers of pneumonia using RNA-sequencing and bioinformatics analysis.Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy.
P2860
Q24305261-9759E9AC-2044-4C14-B8C6-5C2703087941Q26769909-F9DD44AE-24A3-49FB-88DE-11D7DD1C7218Q26798148-A1E2C236-0ECC-4790-AF29-1460E213FAB2Q28066915-ACF1610E-3E91-4522-A94D-F133D47A7346Q28275692-E4E28DCD-E16B-4EF0-861B-0812AC795209Q28817795-F5E5D814-B65F-4092-85C8-D5FB38356634Q33598695-0D86429C-3574-46F7-A81A-6FC84FED9108Q33688508-F2B87B63-D7E9-4AA3-97AB-1A10D8F145CEQ34178271-F818926F-9B16-4FB0-AECC-90F85368F263Q34372539-E9B91B37-B057-4BB0-BB73-3FBFDC8E4927Q34447216-C1616671-19E2-4F84-98C1-E690CCC965F4Q34498701-58D95764-F2EF-45EE-93A6-7EF910B8EECEQ34697766-4059C680-0085-46F9-81E3-2796313EDCAFQ35044740-8795749B-4F69-4143-84CD-CDD4092BEBD4Q35107709-297114EC-256D-42E1-BC27-A582C3EC7473Q35119047-42AD2011-EEFC-43CD-B480-104E5CFC0922Q35133477-FE661B7B-F58E-4B0D-B22B-0D913380F2DCQ35145133-935AC9BE-32D8-4843-BDFF-6F406F35D553Q35450183-029CD4BC-B70C-4B1A-8839-A7F79742A1D9Q35644614-99B01CCE-C917-4F6A-8DD4-7801E3DDABC7Q35689888-2F1804CA-F09F-41EB-ADCE-A1FC027EE667Q35692268-6CE81E34-F567-469D-BA88-09D8DFEB8C7AQ35693081-FE2320B0-907C-440D-91C3-055FEE390CFDQ35742205-DC7E2AFE-0D72-4BDA-9C4E-353EF3F5637CQ35822289-64FF66CB-5474-41CD-B941-BCA8217DC26DQ35937670-E5A93537-6FF0-4D65-AC0D-5BD62E64D423Q35962308-D1DF55A2-F8FB-4F08-8C7B-C097AF49DEBAQ36108838-682B433D-2718-4A07-88E7-70C188F0834AQ36308942-F8E47411-7282-4EF8-9C0F-4527C36049D3Q36557126-C24A30AD-3EF4-4BAF-BCFE-51242C8A492BQ36631204-D44ECEEB-C844-42D8-8888-272519896A0FQ36772451-55DC4BC7-1C74-4110-BD6B-72E9554AFAE9Q37254393-F22D88A6-B3C2-4887-B604-FF09A740735BQ37304724-B5332B29-1D0F-4CA3-87BC-D4EE42506F3AQ37527851-629FCB19-631D-4932-971E-F89D3F7F1781Q37589507-03A55A9E-AC4B-49F6-A388-A05B231B21D7Q37705834-8C2E6BEA-45E6-4FA4-B91C-6C3868A74D89Q37734374-84E91D1B-F393-4FD0-A7B4-D080C0710C39Q37734509-B3DFEA27-F446-44CB-8577-C774A749D211Q38289057-B6B10ABD-FA9F-43D1-96CF-265A9421FBC0
P2860
Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Global profiling and molecular ...... s misregulated in lung cancer.
@ast
Global profiling and molecular ...... s misregulated in lung cancer.
@en
type
label
Global profiling and molecular ...... s misregulated in lung cancer.
@ast
Global profiling and molecular ...... s misregulated in lung cancer.
@en
prefLabel
Global profiling and molecular ...... s misregulated in lung cancer.
@ast
Global profiling and molecular ...... s misregulated in lung cancer.
@en
P2093
P2860
P356
P1476
Global profiling and molecular ...... s misregulated in lung cancer.
@en
P2093
Benjamin J Blencowe
C Jane McGlade
Christine M Misquitta-Ali
Dave O'Hanlon
Edith Cheng
P2860
P304
P356
10.1128/MCB.00709-10
P407
P577
2010-11-01T00:00:00Z